15Oct 2019

A REVIEW ARTICLE OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

  • MBBS, Medical Intern, College of Medicine, Taibah University, Saudi Arabia
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Childhood acute lymphoblastic leukemia is a malignant disorder that originates in a single B or T lymphocyte progenitor. Worldwide, it is the most common childhood cancer. It accounts 25% of all childhood cancers and approximately 75% of all cases of childhood leukemia. Although contemporary treatments have been effective in curing more than 80% of children with acute lymphoblastic leukemia; however, some patients develop fatal acute and delayed complications as a result of side effects from the medications requiring more aggressive management. Objective: Detect the recent incidence of childhood acute lymphoblastic leukemia and causes of that. Also discuss the treatment strategies of childhood acute lymphoblastic leukemia and their late possible effects. Methods:The data was collected from PubMed, Medline, SDL, Up to date and Springer databases. The search terms were childhood acute lymphoblastic leukemia, incidence, classification, biology, pathophysiology, clinical manifestations, causes, risk factors, treatment, survival rate, long-term outcomes, worldwide and Saudi Arabia. Conclusion:Childhood acute lymphoblastic leukemia incidence rates are generally higher in developed than in developing countries. The risk factors of childhood acute lymphoblastic leukemia are environmental and genetic factors. The late effects of acute lymphoblastic leukemia treatment mainly are increasing of cardiovascular morbidity and mortality, neurocognitive impairment, endocrine dysfunction and metabolic abnormalities. There are multiple new treatments that might improve the overall response of patients like molecular therapies that target genetic abnormalities of the leukemic cells and their affected signaling pathways

  1. Global cancer facts & figures 2nd edition, 2008. American Cancer Society, Inc. 2011; No.86181.
  2. Rana ZA, Rabbani MW, Sheikh MA, Khan AA. Outcome of childhood acute lymphoblastic leukemia after induction therapy--3 years experience at a single pediatric oncology centre. Journal of Ayub Medical College Abbottabad. 2009; 21(4):150-153.
  3. Al-Eid HS and Garcia AD. Cancer incidence report, Saudi Arabia, 2009. Saudi Cancer Registry. 2012.
  4. ALBakr RB, Khojah OT. Incidence trend of the leukemia reported cases in the kingdom of Saudi Arabia, observational descriptive statistic from Saudi cancer registry. International journal of biomedical research. 2014; 5 (8): 522-524.
  5. Bhutani M, Kochupillai V & Bakhshi S. Childhood acute lymphoblastic leukemia: Indian experience. Indian journal of medical & pediatric oncology. 2004; 25: 3-8.
  6. Al-Mutlaq HM, Bawazir AA, Jradi H, Al-Dhalaan ZA, Al-Shehri A. Patterns of childhood cancer incidence in Saudi Arabia (1999- 2008). Asian pacific journal of cancer prevention. 2015; 16(2):431-435.
  7. Forero RM, Hernandez M, Hernandez-Rivas JM. Genetics of Acute Lymphoblastic Leukemia, Leukemia. 2013. Available from: http://www.intechopen.com/books/leukemia/genetics-of-acute-lymphoblastic-leukemia.
  8. Buitenkamp T, Izraeli S, Zimmermann M, Forestier E, Heerema N, van den Heuvel-Eibrink M et al. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood. 2014;123(1):70-77.
  9. Hutter JJ. Childhood Leukemia. Pediatrics in review. 2010; 31(6): 234-241.
  10. Infante-Rivard C, Amre DK. Congenital anomalies in children with acute lymphoblastic leukemia and in their family. International journal of epidemiology. 2001; 30 (2): 350-352.
  11. Odenike OM, Michaelis LC, Stock W. Acute lymphoblastic leukemia. Oncology. 2006: 1182-1209.
  12. Kroll M, Stiller C, Murphy M, Carpenter L. Childhood leukaemia and socioeconomic status in England and Wales 1976?2005: evidence of higher incidence in relatively affluent communities persists over time. Br J Cancer. 2011;105(11):1783-1787.
  13. Thompson J, Gerald P, Willoughby M, Armstrong B. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukemia in childhood: a case-control study. The Lancet. 2001;358(9297):1935-1940
  14. Arya LS. Acute lymphoblastic leukemia: current therapy. Indian journal of medical and pediatric oncology. 2004; 25(5): 11-17.
  15. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukemia. Lancet 2008; 371:1030?1043.
  16. Peters C, Schrappe M, Stackelberg VA, Schrauder A, Bader P, Ebell W et al. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. Journal of Clinical Oncology. 2015; 33(11): 1265-1274.
  17. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC et al. Treatment of childhood acute lymphoblastic leukemia without prophylactic cranial irradiation. New England journal of medicine. 2009; 360(26): 2730?2741.
  18. 18-Mody R, Li S, Dover D, Sallan S, Leisenring W, Oeffinger K et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111(12):5515-5523.
  19. Ness KK, Armenian SH, Kadan-Lottick N, Gurney JG. Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert review of hematology. 2011; 4(2):185-197.
  20. Borugian MJ, Spinelli JJ, Mezei G, Wilkins R, Abanto Z, McBride ML. Childhood?leukemia?and socioeconomic status in Canada. Epidemiology. 2005; 16(4):526-31.
  21. Poole C, Greenland S, Luetters C, Kelsey JL, Mezei G. Socioeconomic status andchildhood?leukemia: a review. Int J Epidemiol.?2006 Apr;35(2):370-84.
  22. Chang JS. Parental smoking and childhood leukemia. Methods Mol Biol. 2009; 472:103-37.
  23. McNally RJ, Parker L. Environmental factors and childhood acute leukemias and lymphomas. Leuk Lymphoma. 2006; 47(4):583-98.
  24. Zhou Y, Zhang S, Li Z, Zhu J, Bi Y, Bai Y, Wang H. Maternal Benzene Exposure during Pregnancy and Risk of Childhood Acute Lymphoblastic Leukemia: A Meta-Analysis of Epidemiologic Studies. PLoS One. 2014; 9(10): e110466.
  25. Bzhalava D, Hultin E, Arroyo M?hr LS, Ekstr?m J, Lehtinen M, de Villiers EM, Dillner J. Viremia during pregnancy and risk of childhood leukemia and lymphomas in the offspring: Nested case-control study. Int J Cancer.2016 May 1;138(9):2212-20.
  26. Chessells J, Harrison G, Richards S, Bailey C, Hill F, Gibson B, Hann I. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment. Arch Dis Child. 2001 Oct; 85(4): 321?325.
  27. Aljamaan K, Aljumah TK, Aloraibi S, Absar M, Iqbal Z. Low frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian pediatric acute lymphoblastic leukemia patients: association with clinical parameters and early remission. Asian pacific journal of cancer prevention. 2015; 16(17):7523-7527.
  28. Teitell MA and?Pandolfi PP. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol.2009; 4:175-98.
  29. Larson R, Anastasi J. Acute Lymphoblastic Leukemia: Clinical Presentation, Diagnosis, and Classification. Acute Leukemias. 2008:109-118.
  30. Esparza SD, Sakamoto KM. Topics in pediatric leukemia ? acute lymphoblastic leukemia. MedGenMed. 2005; 7(1): 23.
  31. Rubnitz JE and Pui CH. Childhood Acute Lymphoblastic Leukemia. The Oncologist 1997; 2:374-380.
  32. Pui CH, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukemia. Nat Rev Drug Discov. 2007 Feb; 6(2):149-65.
  33. Schrauder A, Reiter A, Gadner H, Niethammer D, Klingebiel T, Kremens B, et al. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. J Clin Oncol. 2006 Dec 20;24(36):5742-9.
  34. Gutierrez A, Look AT. Molecular Targeted Therapies in T-Cell Acute Lymphoblastic Leukemia. Molecularly Targeted Therapy for Childhood Cancer. 2010; 19-30.
  35. Veerman AJ1, Hahlen K, Kamps WA, Van Leeuwen EF, De Vaan GA, Solbu G, Suciu S, Van Wering ER, Van der Does-Van der Berg A. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol. 1996 Mar;14(3):911-8.
  36. Rae C, Furlong W, Jankovic M, Moghrabi A, Naqvi A, Sala A, et al. Economic evaluation of treatment for acute lymphoblastic leukemia in childhood. Eur J Cancer Care (Engl). 2014 Nov; 23(6):779-85.
  37. Jarvela L. CARDIOVASCULAR HEALTH AND FITNESS AFTER CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA. 2015.
  38. Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort. Br J Haematol. 2014 May; 165(3):364-74.
  39. Warner JT. Body composition, exercise and energy expenditure in survivors of acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2008 Feb; 50(2 Suppl):456-61; discussion 468.
  40. Hata M, Ogino I, Aida N, Saito K, Omura M, Kigasawa H, et al. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors. Int J Cancer. 2001; 96 Suppl:117-24.
  41. Hunger S, Mullighan C. Acute Lymphoblastic Leukemia in Children. New England Journal of Medicine. 2015;373(16):1541-1552.

[Ghaidaa Saleh Almohammadi (2019); A REVIEW ARTICLE OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA Int. J. of Adv. Res. 7 (Oct). 1273-1279] (ISSN 2320-5407). www.journalijar.com

Ghaida’a Saleh Almohammadi.
Taibah University

DOI:

Article DOI: 10.21474/IJAR01/9954      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9954

Download Full Paper

Download PDF No. of Downloads: 159 | No. of Views: 356